WinstonWınston

Deep Value: cash covers more than 100% of the stock price

This company holds roughly $71M in cash and investments — more than its entire stock-market value, based on its latest quarterly filing. You're paying very little for the actual business. Sometimes that's a genuine bargain or a takeover target, sometimes it's cheap for a reason. Not a buy signal on its own — always ask why it's this cheap.

Cordlife Group Limited logo

Cordlife Group Limited

CLIFF
27
Medical - Diagnostics & Research · Healthcare
Price
$0.15
+0.00 (+0.00%)
Market Cap
$38.6M
Exchange
Other OTC
Winston Score
27
Winston is worried
Below-average fundamentals — multiple weak pillars.
Data as of Aug 9, 2026 · filings through Mar 31, 2026

Cordlife Group Limited is a Singapore-based company that stores umbilical cord blood and cord tissue for families after a baby is born. The idea is that these samples contain stem cells, which could potentially be used to treat certain diseases later in life. Cordlife serves parents across Southeast Asia and parts of South Asia, including markets like Singapore, India, Indonesia, the Philippines, and Hong Kong.

The company charges families an upfront fee plus annual storage fees to keep their samples safe in special facilities, making it a mix of one-time and recurring revenue. Cordlife has built its business around trust and accreditation, since parents are handing over something irreplaceable. However, the company has faced serious regulatory and reputational damage after a 2023 incident in Singapore where stored samples were exposed to improper temperatures, raising questions about storage quality. Rebuilding customer confidence and regulatory standing is the central challenge the business faces going forward.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-6.2% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+25.6% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

4.6%ownership

Relatively low insider ownership

Cash Runway

5+ years

Quarterly Free Cash Flow

↓ Burn rate worsening

$121M cash & investments at current burn rate

Revenue declining

Cordlife Group Limited's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

+0.0% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 256.2M (2021) → 256.3M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
56.4%
Premium pricing power — 56.4% gross margin
Operating Margin
-27.3%
Losing money on operations — -27.3%
ROCE
-2.3%
Weak — -2.3% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+17.2%
Fast-growing sales (+17.2% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-5.5%
Burning cash (-5.5%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.04
Conservative — low debt load (0.04)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial